Clinical Features and Outcomes of Parkinson's Disease with Coronavirus Disease 2019 (COVID-19) in Wuhan: A Single Center, Retrospective, Observational Study
Heng Zhai(Union Hospital), Yan Xu(Union Hospital), Yinzhang Lv(Tongji Hospital), Xuebing Cao(Union Hospital), Yu Xu(Union Hospital), Weiqi Zeng(Fujian University of Traditional Chinese Medicine), Tao Wang(Huazhong University of Science and Technology), Yi Wu(Huazhong University of Science and Technology)
Cited by 1
Related Papers
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management
|Orphanet Journal of Rare Diseases|2014|315
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
|Nature Communications|2015|280
Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies
|Cell|2023|153
TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
|Proceedings of the National Academy of Sciences|2017|133